Acasti Pharma Incの価格/簿価
Acasti Pharma Incの価格/簿価は何ですか。
Acasti Pharma Incの価格/簿価は0.13です。
価格/簿価の定義は何ですか。
株価純資産倍率は、会社の株価と1株当たりの簿価との比率を表します。
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
NASDAQのセクタHealth Careにおける価格/簿価の企業と比べるAcasti Pharma Inc
Acasti Pharma Incは何をしますか。
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
Acasti Pharma Incと類似の価格/簿価
- Brighthouseの価格/簿価は0.13です。
- Kirloskar Electricの価格/簿価は0.13です。
- Educomp Solutionsの価格/簿価は0.13です。
- Plastiques du Val de Loireの価格/簿価は0.13です。
- Hang Lungの価格/簿価は0.13です。
- Polo Resourcesの価格/簿価は0.13です。
- Acasti Pharma Incの価格/簿価は0.13です。
- Value8 N.Vの価格/簿価は0.13です。
- SandRidge Permian Trustの価格/簿価は0.13です。
- Ulta Beautyの価格/簿価は0.13です。
- Avayaの価格/簿価は0.13です。
- Century Ginwa Retailの価格/簿価は0.13です。
- Ever-Glory Internationalの価格/簿価は0.13です。